Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Total Liabilities

Latest as of March 2026: €47.87 Billion EUR ≈ $55.96 Billion USD

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited total liabilities. Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has total liabilities worth €47.87 Billion EUR (≈ $55.96 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Guangzhou Baiyunshan Pharmaceutical Hold asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)

Total liabilities of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025. This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Guangzhou Baiyunshan Pharmaceutical Hold (GU5) investment intensity to see how much of total assets are deployed in long-term investments.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors by Total Liabilities

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Guangdong Banbao Toy Co Ltd SHG:603398	China	CN¥2.73 Billion
American Exceptionalism Acquisition Corp. A NYSE:AEXA	USA	$20.73 Million
Shandong Liancheng Precision Manufacturing Co Ltd Class A SHE:002921	China	CN¥1.00 Billion
Shenzhen Zqgame SHE:300052	China	CN¥366.57 Million
Chongqing Mas Sci&Tech SHE:300275	China	CN¥378.41 Million
Bonree Data Technology Co Ltd SHG:688229	China	CN¥52.56 Million
LB Foster Company NASDAQ:FSTR	USA	$155.25 Million
Simulations Plus Inc NASDAQ:SLP	USA	$13.94 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Guangzhou Baiyunshan Pharmaceutical Hold (GU5) total assets.

Liquidity & Leverage Metrics

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Total Liabilities Ratios Explained

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)

The table below shows the annual total liabilities of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€44.43 Billion ≈ $51.94 Billion	+1.17%
2024-12-31	€43.91 Billion ≈ $51.34 Billion	+4.78%
2023-12-31	€41.91 Billion ≈ $49.00 Billion	+2.15%
2022-12-31	€41.03 Billion ≈ $47.97 Billion	+17.93%
2021-12-31	€34.79 Billion ≈ $40.67 Billion	+10.26%
2020-12-31	€31.55 Billion ≈ $36.89 Billion	+2.11%
2019-12-31	€30.90 Billion ≈ $36.13 Billion	+9.05%
2018-12-31	€28.34 Billion ≈ $33.13 Billion	+213.08%
2017-12-31	€9.05 Billion ≈ $10.58 Billion	+9.80%
2016-12-31	€8.24 Billion ≈ $9.64 Billion	+14.70%
2015-12-31	€7.19 Billion ≈ $8.40 Billion	+13.27%
2014-12-31	€6.34 Billion ≈ $7.42 Billion	+21.39%
2013-12-31	€5.23 Billion ≈ $6.11 Billion	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F:GU5 Germany Medical Distribution

Market Cap

$372.78 Million

€318.86 Million EUR

Market Cap Rank

#13474 Global

#1409 in Germany

Share Price

€1.45

Change (1 day)

+2.11%

52-Week Range

€1.41 - €2.30

All Time High

€2.30